Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

Hans-Jürgen Stellbrink, Eric Le Fevre, Andrew Carr, Michael S. Saag, Geoffrey Mukwaya, Silvia Nozza, Srinivas Rao Valluri, Manoli Vourvahis, Alex R. Rinehart, Lynn McFadyen, Carl Fichtenbaum, Andrew Clark, Charles Craig, Annie F. Fang, Jayvant Heera

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences